| AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model. | |
| Hu Liangshuo; Su Lin; Dong Zhixia; Wu Yunhua; Lv Yi; George Jacob; Wang Jianhua | |
| 刊名 | Journal of molecular medicine
 |
| 2019 | |
| 卷号 | 97页码:423-434 |
| 关键词 | Liver cirrhosis Nitric oxide AMP-activated protein kinase AICAR Portal hypertension |
| ISSN号 | 1432-1440 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2827770 |
| 专题 | 西安交通大学 |
| 推荐引用方式 GB/T 7714 | Hu Liangshuo,Su Lin,Dong Zhixia,et al. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.[J]. Journal of molecular medicine,2019,97:423-434. |
| APA | Hu Liangshuo.,Su Lin.,Dong Zhixia.,Wu Yunhua.,Lv Yi.,...&Wang Jianhua.(2019).AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model..Journal of molecular medicine,97,423-434. |
| MLA | Hu Liangshuo,et al."AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.".Journal of molecular medicine 97(2019):423-434. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论